Welcome to LookChem.com Sign In|Join Free
  • or
Cyclobutyl-oxo-acetic acid, also known as 2-cyclobutyl-2-oxoacetic acid, is a chemical compound with the molecular formula C6H8O3. It is a cyclic carboxylic acid that contains a four-membered cyclobutane ring and a ketone functional group. CYCLOBUTYL-OXO-ACETIC ACID is often used as a building block in organic synthesis and medicinal chemistry, and has been studied for its potential pharmaceutical applications, including its role in the development of novel drugs. Cyclobutyl-oxo-acetic acid exhibits interesting chemical reactivity and can serve as a precursor for the synthesis of various heterocyclic and biologically active compounds. It is also important for the study of structure-activity relationships in medicinal chemistry and drug discovery.

13884-85-0

Post Buying Request

13884-85-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13884-85-0 Usage

Uses

Used in Organic Synthesis:
Cyclobutyl-oxo-acetic acid is used as a building block for the synthesis of various heterocyclic and biologically active compounds, contributing to the development of new organic compounds with potential applications in various fields.
Used in Medicinal Chemistry:
Cyclobutyl-oxo-acetic acid is used as a precursor in the development of novel drugs, leveraging its chemical reactivity to create pharmaceutically relevant molecules. It aids in the exploration of structure-activity relationships, which is crucial for drug discovery and optimization processes.
Used in Pharmaceutical Applications:
Cyclobutyl-oxo-acetic acid is studied for its potential pharmaceutical applications, indicating its use in the creation of new therapeutic agents that could address unmet medical needs or improve existing treatments.
Used in Drug Discovery:
CYCLOBUTYL-OXO-ACETIC ACID is important for the study of structure-activity relationships in medicinal chemistry, which is essential for identifying and optimizing drug candidates with desired pharmacological properties and minimal side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 13884-85-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,8,8 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13884-85:
(7*1)+(6*3)+(5*8)+(4*8)+(3*4)+(2*8)+(1*5)=130
130 % 10 = 0
So 13884-85-0 is a valid CAS Registry Number.

13884-85-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Cyclobutyl-2-oxoacetic acid

1.2 Other means of identification

Product number -
Other names 2-cyclobutyl-2-oxoacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13884-85-0 SDS

13884-85-0Downstream Products

13884-85-0Relevant academic research and scientific papers

Biocatalytic Construction of Quaternary Centers by Aldol Addition of 3,3-Disubstituted 2-Oxoacid Derivatives to Aldehydes

Marín-Valls, Roser,Hernández, Karel,Bolte, Michael,Parella, Teodor,Joglar, Jesús,Bujons, Jordi,Clapés, Pere

supporting information, p. 19754 - 19762 (2020/12/01)

The congested nature of quaternary carbons hinders their preparation, most notably when stereocontrol is required. Here we report a biocatalytic method for the creation of quaternary carbon centers with broad substrate scope, leading to different compound classes bearing this structural feature. The key step comprises the aldol addition of 3,3-disubstituted 2-oxoacids to aldehydes catalyzed by metal dependent 3-methyl-2-oxobutanoate hydroxymethyltransferase from E. coli (KPHMT) and variants thereof. The 3,3,3-trisubstituted 2-oxoacids thus produced were converted into 2-oxolactones and 3-hydroxy acids and directly to ulosonic acid derivatives, all bearing gem-dialkyl, gem-cycloalkyl, and spirocyclic quaternary centers. In addition, some of these reactions use a single enantiomer from racemic nucleophiles to afford stereopure quaternary carbons. The notable substrate tolerance and stereocontrol of these enzymes are indicative of their potential for the synthesis of structurally intricate molecules.

SYNTHESIS METHOD FOR L-CYCLIC ALKYL AMINO ACID AND PHARMACEUTICAL COMPOSITION HAVING THEREOF

-

Paragraph 0064, (2016/11/17)

A synthesis method for L-cyclic alkyl amino acid and a pharmaceutical composition having the said amino acid are provide in the present disclosure provides. The synthesis method comprises: step A.) preparing a cyclic alkyl keto acid or a cyclic alkyl keto acid salt having Structural Formula (I) or Structural Formula (II), and step B.) mixing the cyclic alkyl keto acid or the cyclic alkyl keto acid salt with ammonium formate, a leucine dehydrogenase, a formate dehydrogenase and a coenzyme NAD+, and carrying out a reductive amination reaction to generate the L-cyclic alkyl amino acid, wherein the Structural Formula (I) is where n1≧1, m1≧0 and the M1 is H or a monovalent cation; the Structural Formula (II) is where n2≧0, m2≧0, the M2 is H or a monovalent cation, an amino acid sequence of the leucine dehydrogenase is SEQ ID No.1.

An Evaluation of the Substrate Specificity, and of Its Modification by Site-Directed Mutagenesis, of the Cloned L-Lactate Dehydrogenase from Bacillus stearothermophilus

Luyten, Marcel A.,Bur, Daniel,Wynn, Hla,Parris, Wendy,Glod, Marvin,et al.

, p. 6800 - 6804 (2007/10/02)

The L-lactate dehydrogenase of Bacillus stearothermophilus (BSLDH) is a stable, thermophilic oxidoreductase.It has been selected as a model of enzymes with considerable future promise in assymetric synthesis in that it has been cloned to ensure a plentiful and inexpensive supply and because of the potential for tailoring its specificity to accept unnatural substrate structures via the site-directed mutagenesis techniques of moleculer biology.In this study, the specificity of BSLDH toward representative α-keto acids possessing straight- and branched-chain alkyl,cycloalkyl, or aromatic side chains has been evaluated.The results show that substrates that are sterically bulky in the region of the α-keto group to be reduced are poorly accepted by the enzyme.Graphics analyses indicated that the low activities of these hindered substrates might be partly due to a bad interaction of the active site residue Gln102 with large or branched substituents adjacent to the α-keto group.Accordingly, Gln102 has been replaced by the smaller Asn residue by site-directed mutagenesis in an attempt to expand the active site volume available to receive substrates larger than the natural pyruvate.However, the kinetic data show that bulky α-keto acids are only marginally better accommodated by the Gln102 -> Asn mutant than by the wild-type enzyme.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13884-85-0